Article
Pharmacology & Pharmacy
Hyung-Ju Seo, Seung-Bae Ji, Sin-Eun Kim, Gyung-Min Lee, So-Young Park, Zhexue Wu, Dae Sik Jang, Kwang-Hyeon Liu
Summary: The study found that lignans from Schisandra can inhibit the activity of certain cytochrome P450 enzymes, with some glutathione trapping reactive metabolites. This information may help predict potential drug interactions between Schisandra lignans and other drugs mainly metabolized by P450 enzymes.
Article
Chemistry, Medicinal
Soudeh Bahramian Nasab, Ahmad Homaei, Roberto Fernandez-Lafuente, Jon Del Arco, Jesus Fernandez-Lucas
Summary: The use of marine enzymes as catalysts for biotechnological applications is a hot topic. In this study, a liver NADPH-dependent cytochrome P450 reductase (CPR) from the marine fish Liza klunzingeri (LkCPR) was isolated, purified and biochemically characterized. LkCPR showed remarkable catalytic features, such as a wide range of pH and temperature stability, high catalytic activity, and highest thermostability among reported CPRs. These findings suggest that LkCPR has great potential as a biocatalyst.
Article
Pharmacology & Pharmacy
Christine Wegler, Jacek R. Wisniewski, Ida Robertsen, Hege Christensen, Jens Kristoffer Hertel, Joran Hjelmesaeth, Rasmus Jansson-Lofmark, Anders Asberg, Tommy B. Andersson, Per Artursson
Summary: This study used global proteomics to characterize the protein composition of jejunum and liver in obese donors, revealing the expression of drug-metabolizing enzymes in the jejunum for the first time. The study also showed differences in enzyme expression between the liver and jejunum, indicating the role of the small intestine in drug metabolism. Additionally, the expression of these enzymes was not correlated with physiological factors and did not differ significantly between obese and non-obese donors.
CLINICAL PHARMACOLOGY & THERAPEUTICS
(2022)
Article
Biochemistry & Molecular Biology
Yasuhiro Yonezuka, Hiroki Kuwada, Hiromasa Imaishi
Summary: This study demonstrated the effectiveness of the P450 inhibition assay in a mouse model of DILI, suggesting its potential for diagnosing liver diseases such as acute DILI.
CHEMICO-BIOLOGICAL INTERACTIONS
(2022)
Article
Environmental Sciences
Zhilin Qiu, Guiying Li, Taicheng An
Summary: This study revealed for the first time the toxic effects and metabolic mechanisms of TMA exposure on bronchial epithelial cells. Results indicated that TMA itself and its cellular metabolites may induce toxic effects. Exposure to toxic organic amines may lead to the production of more toxic metabolites in respiratory cells, thereby inducing cellular oxidative stress and necrosis.
SCIENCE OF THE TOTAL ENVIRONMENT
(2021)
Article
Multidisciplinary Sciences
Jannarin Nontakham, Pongpun Siripong, Hitoshi Sato, Savita Chewchinda, Kuntarat Arunrungvichian, Jantana Yahuafai, Arman Syah Goli, Vilasinee Hirunpanich Sato
Summary: This study aimed to investigate the interactions between Triphala and cytochrome P450 (CYP) isoforms and P-glycoprotein (P-gp) through in vitro and in vivo experiments. The results showed that Triphala inhibited the activities of CYP1A and CYP3A, and increased the bioavailabilities of phenacetin and midazolam in rats.
Article
Biochemistry & Molecular Biology
Shaofeng Su, Hongxian Wu, Jingfan Zhou, Guangwei Yuan, Haibo Wang, Jie Feng
Summary: This study evaluated the metabolic kinetics of curcumin and germacrone in liver microsomes and cytochrome P450 enzymes, and found their potential role in anti-NSCLC cancer action. The results suggest the importance of considering drug-drug and drug-enzyme interactions in clinical medication.
Article
Pharmacology & Pharmacy
Line Skute Braten, Tore Haslemo, Marin M. Jukic, Maxim Ivanov, Magnus Ingelman-Sundberg, Espen Molden, Marianne Kristiansen Kringen
Summary: Escitalopram, a commonly used antidepressant drug, shows substantial interindividual variation in clinical response, which can be attributed to the polymorphic nature of the CYP2C19 gene. A novel CYP2C-haplotype associated with ultrarapid metabolism of escitalopram was identified in this study.
CLINICAL PHARMACOLOGY & THERAPEUTICS
(2021)
Article
Biochemistry & Molecular Biology
Shuaibing Liu, Ziteng Wang, Eric Chan, Yibo Zhao, Jian Kang, Xiaojian Zhang, Xin Tian
Summary: Vicagrel, an antiplatelet drug candidate targeting platelet P2Y12 receptor, exhibits potent inhibitory effects on several enzymes, including CYP2B6, CYP2C19, and UGT1A6. Physiological-based pharmacokinetic simulation suggests no clinically significant drug-drug interactions between vicagrel and bupropion or S-mephenytoin.
CHEMICO-BIOLOGICAL INTERACTIONS
(2022)
Article
Chemistry, Multidisciplinary
Gustavo Perez Ortiz, John D. Sidda, Emmanuel L. C. de los Santos, Catherine B. Hubert, Sarah M. Barry
Summary: The antimycobacterial peptides rufomycins exhibit antibiotic activity due to oxidative tailoring of the cyclic peptide. Cytochrome P450s RufS and RufM play roles in regioselective epoxidation and alkyl oxidation, creating a complex product profile dependent on redox partner availability. Additionally, in vitro one pot conversion of rufomycin B to rufomycin C has been successfully demonstrated.
CHEMICAL COMMUNICATIONS
(2021)
Article
Environmental Sciences
Xiaoxia Yang, Xuemei Zhang, Xiao Shu, Jiuping Gong, Junying Yang, Biquan Li, Junjie Lin, Yong Chai, Jianfei Liu
Summary: This study found that polyethylene (PE) microplastics (MPs) smaller than 5 mm exert toxic effects on earthworms, with concentrations exceeding 2.5 g/kg causing significant changes in metabolic enzyme activities and metabolites. The toxicity of PE MPs to earthworms is likely associated with neurotoxicity, oxidative damage, decreased detoxification capacity, energy metabolism imbalance, and impaired amino acid and purine metabolism due to bioaccumulation. The findings of this study contribute to a better understanding of the molecular toxicity mechanisms of PE MPs and the ecological risks they pose.
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
(2023)
Article
Pharmacology & Pharmacy
V. H. Amstutz, A. Cengo, D. T. H. M. Sijm, M. F. Vrolijk
Summary: Per- and polyfluomalkyl substances (PFASs) have been associated with hepatotoxicity, and their interaction with cytochrome P450 (CYP) has been proposed as a potential mechanism. This study explored the inhibitory potential of thirteen PFASs on four CYPs, revealing that most PFASs can inhibit CYP activity. The inhibition mechanism varied among different CYP isoenzymes. Some PFASs also induced increased CYP activity. These findings suggest that multiple novel PFASs may interfere with drug metabolism by affecting CYPs.
Article
Medicine, Research & Experimental
Erzsebet Paszti-Gere, Anna Szentkiralyi, Zsofia Fedor, Gabor Nagy, Zoltan Szimrok, Zoltan Paszti, Anna Paszti, Oliver Pilgram, Torsten Steinmetzer, Slavka Bodnarova, Eszter Fliszar-Nyul, Miklos Poor
Summary: The study investigated the interactions of four inhibitors with serum albumin and CYP isoenzymes, revealing potent inhibition of CYP3A4 and partial degradation of the inhibitors within one hour. The inhibitors showed no significant interaction with albumin and did not inhibit CYP1A2, 2C9, and 2C19.
BIOMEDICINE & PHARMACOTHERAPY
(2022)
Article
Pharmacology & Pharmacy
Christoph Wenzel, Joanna Lapczuk-Romanska, Damian Malinowski, Marek Ostrowski, Marek Drozdzik, Stefan Oswald
Summary: First-pass metabolism in the intestines and liver is crucial for the bioavailability of oral drugs. This study analyzed gene expression and protein abundance of 24 clinically relevant drug-metabolizing enzymes (DMEs) in the intestines and liver, revealing significant inter-individual variability. These findings can provide insights into personalized drug therapy.
CLINICAL PHARMACOLOGY & THERAPEUTICS
(2023)
Article
Chemistry, Physical
Nico D. Fessner, Christopher Grimm, Matic Srdic, Hansjoerg Weber, Wolfgang Kroutil, Ulrich Schwaneberg, Anton Glieder
Summary: This study explores the synthetic potential of human P450 3A4 in diversifying natural product classes, resulting in the identification of 31 authentic human metabolites. With efficient expression levels in P. pastoris, this biocatalyst shows promising results for modifying natural products in a one-step fashion.